Analog Devices (ADI) 10-Q 17 Aug 22 2022 Q3 Quarterly report Financial data

Cover

Cover	9 Months Ended
	Jul. 30, 2022 shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 30, 2022
Document Transition Report	false
Entity File Number	1-7819
Entity Registrant Name	Analog Devices, Inc.
Entity Incorporation, State or Country Code	MA
Entity Tax Identification Number	04-2348234
Entity Address, Address Line One	One Analog Way,
Entity Address, City or Town	Wilmington,
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01887
City Area Code	781
Local Phone Number	935-5565
Title of 12(b) Security	Common Stock $0.16 2/3 par value per share
Entity Trading Symbol	ADI
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	514,341,531
Entity Central Index Key	0000006281
Current Fiscal Year End Date	--10-29
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021
Income Statement [Abstract]
Revenue	$ 3,109,880	$ 1,758,853	$ 8,766,237	$ 4,978,718
Cost of sales	1,066,738	537,669	3,376,578	1,575,526
Gross margin	2,043,142	1,221,184	5,389,659	3,403,192
Operating expenses:
Research and development	431,829	306,617	1,279,510	897,005
Selling, marketing, general and administrative	326,942	206,076	929,615	597,963
Amortization of intangibles	252,864	107,783	759,707	323,217
Special charges, net	138,201	(8,938)	244,603	(8,189)
Total operating expenses	1,149,836	611,538	3,213,435	1,809,996
Operating income:	893,306	609,646	2,176,224	1,593,196
Nonoperating expense (income):
Interest expense	51,189	44,659	152,701	130,204
Interest income	(1,797)	(300)	(2,578)	(799)
Other, net	(4,023)	(6,991)	(24,636)	(21,090)
Total nonoperating expense (income)	45,369	37,368	125,487	108,315
Income before income taxes	847,937	572,278	2,050,737	1,484,881
Provision for income taxes	98,952	68,967	238,402	170,146
Net income	$ 748,985	$ 503,311	$ 1,812,335	$ 1,314,735
Shares used to compute earnings per common share – basic (in shares)	517,011	368,476	521,557	368,834
Shares used to compute earnings per common share – diluted (in shares)	520,550	371,849	525,652	372,457
Basic earnings per common share (in dollars per share)	$ 1.45	$ 1.37	$ 3.47	$ 3.56
Diluted earnings per common share (in dollars per share)	$ 1.44	$ 1.35	$ 3.45	$ 3.53

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ 748,985	$ 503,311	$ 1,812,335	$ 1,314,735
Foreign currency translation adjustments	(9,028)	(2,952)	(31,500)	5,073
Change in fair value of derivative instruments designated as cash flow hedges (net of taxes of $854, $10,657, $1,103 and $6,452, respectively)	2,239	(40,040)	(471)	19,853
Changes in pension plans, net actuarial loss and foreign currency translation adjustments (net of taxes of $88, $85, $275 and $257, respectively)	1,770	964	5,902	(408)
Other comprehensive (loss) income	(5,019)	(42,028)	(26,069)	24,518
Comprehensive income	$ 743,966	$ 461,283	$ 1,786,266	$ 1,339,253

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021
Statement of Comprehensive Income [Abstract]
Change in fair value of derivative instruments designated as cash flow hedges, tax	$ 854	$ 10,657	$ 1,103	$ 6,452
Changes in pension plans, net actuarial loss and foreign currency translation adjustments, tax	$ 88	$ 85	$ 275	$ 257

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 30, 2022	Oct. 30, 2021
Current Assets
Cash and cash equivalents	$ 1,524,960	$ 1,977,964
Accounts receivable	1,742,646	1,459,056
Inventories	1,203,394	1,200,610
Prepaid expenses and other current assets	218,708	740,687
Total current assets	4,689,708	5,378,317
Non-current Assets
Net property, plant and equipment	2,180,048	1,979,051
Goodwill	26,920,335	26,918,470
Intangible assets, net	13,764,444	15,267,170
Deferred tax assets	2,297,122	2,267,269
Other assets	494,513	511,794
Total non-current assets	45,656,462	46,943,754
TOTAL ASSETS	50,346,170	52,322,071
Current Liabilities
Accounts payable	545,068	443,434
Income taxes payable	445,726	332,685
Debt, current	0	516,663
Accrued liabilities	1,450,407	1,477,530
Total current liabilities	2,441,201	2,770,312
Non-current Liabilities
Long-term debt	6,252,839	6,253,212
Deferred income taxes	3,764,370	3,938,830
Income taxes payable	712,982	811,337
Other non-current liabilities	536,187	555,838
Total non-current liabilities	11,266,378	11,559,217
Shareholders’ Equity
Preferred stock, $1.00 par value, 471,934 shares authorized, none outstanding	0	0
Common stock, $0.16 2/3 par value, 1,200,000,000 shares authorized, 514,341,531 shares outstanding (525,330,672 on October 30, 2021)	85,725	87,554
Capital in excess of par value	28,590,056	30,574,237
Retained earnings	8,175,444	7,517,316
Accumulated other comprehensive loss	(212,634)	(186,565)
Total shareholders’ equity	36,638,591	37,992,542
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 50,346,170	$ 52,322,071

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jul. 30, 2022	Oct. 30, 2021
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	471,934	471,934
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.16	$ 0.16
Common stock, shares authorized (in shares)	1,200,000,000	1,200,000,000
Common stock, shares outstanding (in shares)	514,341,531	525,330,672

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Capital in Excess of Par Value	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Oct. 31, 2020		369,485
Beginning balance at Oct. 31, 2020		$ 61,582	$ 4,949,586	$ 7,236,238	$ (249,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 1,314,735			1,314,735
Dividends declared and paid				(738,114)
Issuance of stock under stock plans and other (in shares)		2,040
Issuance of stock under stock plans and other		$ 340	55,008
Stock-based compensation expense			118,683
Other comprehensive income (loss)	$ 24,518				24,518
Common stock repurchased (in shares)		(3,311)
Common stock repurchased		$ (552)	(508,600)
Ending balance (in shares) at Jul. 31, 2021		368,214
Ending balance at Jul. 31, 2021		$ 61,370	4,614,677	7,812,859	(224,943)
Beginning balance (in shares) at Oct. 31, 2020		369,485
Beginning balance at Oct. 31, 2020		$ 61,582	4,949,586	7,236,238	(249,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchased (in shares)	(12,300)
Ending balance (in shares) at Oct. 30, 2021		525,331
Ending balance at Oct. 30, 2021	$ 37,992,542	$ 87,554	30,574,237	7,517,316	(186,565)
Beginning balance (in shares) at Oct. 31, 2020		369,485
Beginning balance at Oct. 31, 2020		$ 61,582	4,949,586	7,236,238	(249,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock repurchased (in shares)	(14,400)
Ending balance (in shares) at Jul. 30, 2022		514,341
Ending balance at Jul. 30, 2022	$ 36,638,591	$ 85,725	28,590,056	8,175,444	(212,634)
Beginning balance (in shares) at May. 01, 2021		368,827
Beginning balance at May. 01, 2021		$ 61,472	4,724,493	7,564,054	(182,915)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	503,311			503,311
Dividends declared and paid				(254,506)
Issuance of stock under stock plans and other (in shares)		396
Issuance of stock under stock plans and other		$ 66	11,610
Stock-based compensation expense			41,687
Other comprehensive income (loss)	(42,028)				(42,028)
Common stock repurchased (in shares)		(1,009)
Common stock repurchased		$ (168)	(163,113)
Ending balance (in shares) at Jul. 31, 2021		368,214
Ending balance at Jul. 31, 2021		$ 61,370	4,614,677	7,812,859	(224,943)
Beginning balance (in shares) at Oct. 30, 2021		525,331
Beginning balance at Oct. 30, 2021	37,992,542	$ 87,554	30,574,237	7,517,316	(186,565)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,812,335			1,812,335
Dividends declared and paid				(1,154,207)
Issuance of stock under stock plans and other (in shares)		2,396
Issuance of stock under stock plans and other		$ 400	29,613
Stock-based compensation expense			242,809
Other comprehensive income (loss)	(26,069)				(26,069)
Common stock repurchased (in shares)		(13,386)
Common stock repurchased		$ (2,229)	(2,256,603)
Ending balance (in shares) at Jul. 30, 2022		514,341
Ending balance at Jul. 30, 2022	36,638,591	$ 85,725	28,590,056	8,175,444	(212,634)
Beginning balance (in shares) at Apr. 30, 2022		519,806
Beginning balance at Apr. 30, 2022		$ 86,636	29,400,284	7,820,477	(207,615)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	748,985			748,985
Dividends declared and paid				(394,018)
Issuance of stock under stock plans and other (in shares)		413
Issuance of stock under stock plans and other		$ 69	9,891
Stock-based compensation expense			84,874
Other comprehensive income (loss)	(5,019)				(5,019)
Common stock repurchased (in shares)		(5,878)
Common stock repurchased		$ (980)	(904,993)
Ending balance (in shares) at Jul. 30, 2022		514,341
Ending balance at Jul. 30, 2022	$ 36,638,591	$ 85,725	$ 28,590,056	$ 8,175,444	$ (212,634)

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021
Statement of Stockholders' Equity [Abstract]
Dividends (in dollars per share)	$ 0.76	$ 0.69	$ 2.21	$ 2

Condensed Consolidated Statem_6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021	Oct. 30, 2021
Cash flows from operating activities:
Net income	$ 748,985	$ 503,311	$ 1,812,335	$ 1,314,735
Adjustments to reconcile net income to net cash provided by operations:
Depreciation			212,635	158,937
Amortization of intangibles			1,512,250	436,734
Stock-based compensation expense			242,809	118,683
Non-cash impairment charge			91,953	0
Gain on sale of property, plant, and equipment			(4,352)	(13,557)
Cost of goods sold for inventory acquired			271,396	0
Deferred income taxes			(205,128)	(72,578)
Non-cash operating lease costs			(17,958)	16,855
Other			(7,061)	(14,965)
Changes in operating assets and liabilities			(582,813)	(150,499)
Total adjustments			1,513,731	479,610
Net cash provided by operating activities			3,326,066	1,794,345
Cash flows from investing activities:
Additions to property, plant and equipment			(394,796)	(212,899)
Other			43,761	29,619
Net cash used for investing activities			(351,035)	(183,280)
Cash flows from financing activities:
Proceeds from revolver			400,000	0
Payments on revolver			400,000	0
Early termination of debt			(519,116)	0
Dividend payments to shareholders			(1,154,207)	(738,114)
Repurchase of common stock			(1,758,832)	(509,152)
Proceeds from employee stock plans			30,013	55,348
Other			(1,718)	1,952
Net cash used for financing activities			(3,403,860)	(1,189,966)
Effect of exchange rate changes on cash			(24,175)	3,742
Net (decrease) increase in cash and cash equivalents			(453,004)	424,841
Cash and cash equivalents at beginning of period			1,977,964	1,055,860	$ 1,055,860
Cash and cash equivalents at end of period	$ 1,524,960	$ 1,480,701	$ 1,524,960	$ 1,480,701	$ 1,977,964

Basis of Presentation

Basis of Presentation	9 Months Ended
	Jul. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation In the opinion of management, the information furnished in the accompanying condensed consolidated financial statements reflects all normal recurring adjustments that are necessary to fairly state the results for these interim periods and should be read in conjunction with Analog Devices, Inc.’s (the Company) Annual Report on Form 10-K for the fiscal year ended October 30, 2021 (fiscal 2021) and related notes. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for the fiscal year ending October 29, 2022 (fiscal 2022) or any future period. The Company has a 52-53 week fiscal year that ends on the Saturday closest to the last day in October. Certain amounts reported in previous periods have been reclassified to conform to the fiscal 2022 presentation. On August 26, 2021 (Acquisition Date), the Company completed the acquisition of Maxim Integrated Products, Inc. (Maxim), an independent manufacturer of innovative analog and mixed-signal products and technologies. The acquisition of Maxim is referred to as the Acquisition. The consolidated financial statements included in this Quarterly Report on Form 10-Q include the financial results of Maxim prospectively from the Acquisition Date. See Note 14, Acquisitions , in these Notes to Condensed Consolidated Financial Statements for additional information.

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Jul. 30, 2022
Stockholders' Equity Note [Abstract]
Shareholders' Equity	Shareholders' Equity In fiscal 2021, the Company entered into accelerated share repurchase agreements (ASR) with third party financial institutions, paid $2.5 billion and received an initial delivery of 12.3 million shares of common stock, which represented approximately 80% of the notional amount of the ASR. As of October 30, 2021, the Company recorded the remaining 20%, or $500.0 million, within Prepaid expenses and other current assets on the Consolidated Balance Sheet, which was utilized during the first quarter of fiscal 2022. During the first quarter of fiscal 2022, the ASR was completed and an additional 2.1 million shares of common stock were received as final settlement of the ASR. In total, the Company repurchased 14.4 million shares under the ASR at an average price per share of $173.77. As of July 30, 2022, the Company had repurchased a total of approximately 184.3 million shares of its common stock for approximately $10.9 billion under the Company's share repurchase program. As of July 30, 2022, an additional $5.7 billion remains available for repurchase of shares under the current authorized program. The Company also repurchases shares in settlement of employee tax withholding obligations due upon the vesting of restricted stock units/awards or the exercise of stock options. Future repurchases of common stock will be dependent upon the Company's financial position, results of operations, outlook, liquidity and other factors deemed relevant by the Company.

Accumulated Other Comprehensive

Accumulated Other Comprehensive (Loss) Income	9 Months Ended
	Jul. 30, 2022
Equity [Abstract]
Accumulated Other Comprehensive (Loss) Income	Accumulated Other Comprehensive (Loss) Income The following table provides the changes in accumulated other comprehensive (loss) income (AOCI) by component and the related tax effects during the first nine months of fiscal 2022. Foreign currency translation adjustment Unrealized holding gains (losses) on derivatives Pension plans Total October 30, 2021 $ (25,795) $ (123,754) $ (37,016) $ (186,565) Other comprehensive (loss) income before reclassifications (31,500) (27,471) 4,513 (54,458) Amounts reclassified out of other comprehensive income — 28,103 1,664 29,767 Tax effects — (1,103) (275) (1,378) Other comprehensive (loss) income (31,500) (471) 5,902 (26,069) July 30, 2022 $ (57,295) $ (124,225) $ (31,114) $ (212,634) The amounts reclassified out of AOCI into the Condensed Consolidated Statements of Income and the Condensed Consolidated Statements of Shareholders' Equity with presentation location during each period were as follows: Three Months Ended Nine Months Ended Comprehensive (Loss) Income Component July 30, 2022 July 31, 2021 July 30, 2022 July 31, 2021 Location Unrealized holding (gains) losses on derivatives Currency forwards $ 2,520 $ (351) $ 6,384 $ (3,700) Cost of sales 1,320 (283) 3,903 (2,138) Research and development 2,265 28 6,623 (1,796) Selling, marketing, general and administrative Interest rate derivatives 3,731 464 11,193 1,391 Interest expense 9,836 (142) 28,103 (6,243) Total before tax (423) (28) (3,209) 505 Tax $ 9,413 $ (170) $ 24,894 $ (5,738) Net of tax Amortization of pension components included in the computation of net periodic pension cost Actuarial losses 529 747 1,664 2,245 (88) (85) (275) (257) Tax $ 441 $ 662 $ 1,389 $ 1,988 Net of tax Total amounts reclassified out of AOCI, net of tax $ 9,854 $ 492 $ 26,283 $ (3,750)

Earnings Per Share

Earnings Per Share	9 Months Ended
	Jul. 30, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended Nine Months Ended July 30, 2022 July 31, 2021 July 30, 2022 July 31, 2021 Net Income $ 748,985 $ 503,311 $ 1,812,335 $ 1,314,735 Basic shares: Weighted-average shares outstanding 517,011 368,476 521,557 368,834 Earnings per common share basic: $ 1.45 $ 1.37 $ 3.47 $ 3.56 Diluted shares: Weighted-average shares outstanding 517,011 368,476 521,557 368,834 Assumed exercise of common stock equivalents 3,539 3,373 4,095 3,623 Weighted-average common and common equivalent shares 520,550 371,849 525,652 372,457 Earnings per common share diluted: $ 1.44 $ 1.35 $ 3.45 $ 3.53 Anti-dilutive shares related to: Outstanding stock-based awards 755 645 559 502

Special Charges, Net

Special Charges, Net	9 Months Ended
	Jul. 30, 2022
Restructuring and Related Activities [Abstract]
Special Charges, Net	Special Charges, Net Liabilities related to special charges, net are included in Accrued liabilities in the Condensed Consolidated Balance Sheets. The activity is detailed below: Accrued Special Charges Closure of Manufacturing Facilities Global Repositioning Actions Balance at October 30, 2021 $ 25,774 $ 21,065 Employee severance and benefit costs 75 44,411 Facility closure costs 6,513 — Severance and benefit payments (4,016) (25,776) Facility closure cost payments (6,513) — Effect of foreign currency on accrual — (54) Balance at January 29, 2022 $ 21,833 $ 39,646 Employee severance and benefit costs — 39,610 Facility closure costs 4,287 — Severance and benefit payments (14,026) (25,608) Facility closure cost payments (4,287) — Effect of foreign currency on accrual — (156) Balance at April 30, 2022 $ 7,807 $ 53,492 Employee severance and benefit costs — 49,712 Facility closure costs 888 — Severance and benefit payments (4,663) (44,638) Facility closure cost payments (1,303) — Effect of foreign currency on accrual — (35) Balance at July 30, 2022 $ 2,729 $ 58,531 Closure of Manufacturing Facilities The Company recorded net special charges of $63.4 million on a cumulative basis through July 30, 2022 as a result of its decision to consolidate certain wafer and test facility operations acquired as part of the acquisition of Linear Technology Corporation. During the third quarter of fiscal 2022, the Company completed the sale of its Hillview wafer fabrication facility and certain equipment located in Milpitas, California, which were previously classified as held for sale, for approximately $31.8 million, which resulted in a gain of $4.4 million. During fiscal 2021, the Company completed the sale of its facility and certain equipment in Singapore, which were previously classified as held for sale, for approximately $35.7 million, which resulted in a gain of $13.6 million. Global Repositioning Actions The Company recorded net special charges of $458.1 million on a cumulative basis through July 30, 2022, as part of the integration of the Acquisition and continued organizational initiatives to consolidate its footprint related to certain manufacturing, engineering, sales, marketing and administrative offices and to better align its global workforce with the Company's long-term strategic plan. In connection with the Company’s decision during the third quarter of fiscal 2022 to transition its engineering, sales, marketing and administrative activities from its leased property in Santa Clara, California to its owned property in San Jose, California, the Company entered into a sublease agreement for a portion of the leased property and intends to sublease the remainder of this property. As a result of the sublease transaction, the Company recorded an impairment charge of $91.9 million in net special charges which represented the excess carrying value of the associated asset group over its estimated fair value. The Company estimated fair value using cash flows from the estimated net sublease rental income discounted at a market rate. The Company allocated $60.6 million, $28.1 million and $3.2 million of the impairment charge to right of use assets, leasehold improvements and office equipment, respectively. Special charges also included $145.2 million in the first nine months of fiscal 2022 primarily consisting of $153.5 million of severance and benefit costs as well as charges recorded from the acceleration of equity awards in connection with the termination of certain employees in manufacturing, engineering and selling, marketing, general and administrative roles at sites assumed related to the Acquisition and various locations throughout the world. These charges were partially offset by a gain of $8.3 million recognized upon the sale of a business.

Commitment and Contingencies

Commitment and Contingencies	9 Months Ended
	Jul. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and ContingenciesOn March 17, 2022, Walter E. Ryan and Ryan Asset Management, LLC, purported stockholders of Maxim, filed a putative class action in the Court of Chancery of the State of Delaware (C.A. No. 2022—0255) against the Company and the former directors of Maxim. The complaint alleges breach of fiduciary duties by the individual defendants in connection with Maxim’s agreement, as part of the merger negotiations with the Company, to suspend Maxim dividends for up to four quarters prior to the closing of the Acquisition. The complaint further alleges that the Company aided and abetted that alleged breach of fiduciary duties. The plaintiffs seek damages in an amount to be determined at trial, plaintiffs’ costs and disbursements, including reasonable attorneys’ and experts’ fees, costs and other expenses. The Company believes that it and the other defendants have meritorious defenses to these allegations; however, the Company is currently unable to determine the ultimate outcome of this matter or determine an estimate, or a range of estimates, of potential losses, if any.

Revenue

Revenue	9 Months Ended
	Jul. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Revenue Trends by End Market The following table summarizes revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the “ship to” customer information and the end customer product or application into which the Company’s product will be incorporated. As data systems for capturing and tracking this data and the Company's methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, the Company reclassifies revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of revenue within, each end market. Three Months Ended July 30, 2022 July 31, 2021 Revenue % of Revenue* Y/Y% Revenue % of Revenue* Industrial $ 1,555,070 50 % 55 % $ 1,006,383 57 % Automotive 659,090 21 % 127 % 290,182 16 % Communications 490,732 16 % 69 % 290,391 17 % Consumer 404,988 13 % 136 % 171,897 10 % Total revenue $ 3,109,880 100 % 77 % $ 1,758,853 100 % Nine Months Ended July 30, 2022 July 31, 2021 Revenue % of Revenue* Y/Y% Revenue % of Revenue* Industrial $ 4,402,912 50 % 55 % $ 2,841,665 57 % Automotive 1,844,017 21 % 132 % 794,739 16 % Communications 1,376,182 16 % 62 % 850,153 17 % Consumer 1,143,126 13 % 132 % 492,161 10 % Total revenue $ 8,766,237 100 % 76 % $ 4,978,718 100 % * The sum of the individual percentages may not equal the total due to rounding. Revenue by Sales Channel The following table summarizes revenue by channel. The Company sells its products globally through a direct sales force, third party distributors, independent sales representatives and via its website. Distributors are customers that buy products with the intention of reselling them. Direct customers are non-distributor customers and consist primarily of original equipment manufacturers (OEMs). Other customers include the U.S. government, government prime contractors and certain commercial customers for which revenue is recorded over time. Three Months Ended July 30, 2022 July 31, 2021 Channel Revenue % of Revenue* Revenue % of Revenue* Distributors $ 1,922,982 62 % $ 1,123,301 64 % Direct customers 1,146,538 37 % 588,001 33 % Other 40,360 1 % 47,551 3 % Total revenue $ 3,109,880 100 % $ 1,758,853 100 % Nine Months Ended July 30, 2022 July 31, 2021 Channel Revenue % of Revenue* Revenue % of Revenue* Distributors $ 5,426,024 62 % $ 3,162,615 64 % Direct customers 3,241,429 37 % 1,724,012 35 % Other 98,784 1 % 92,091 2 % Total revenue $ 8,766,237 100 % $ 4,978,718 100 % * The sum of the individual percentages may not equal the total due to rounding.

Fair Value

Fair Value	9 Months Ended
	Jul. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value	Fair ValueThe Company defines fair value as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. The tables below, set forth by level, presents the Company’s financial assets and liabilities, excluding accrued interest components that were accounted for at fair value on a recurring basis as of July 30, 2022 and October 30, 2021. The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of July 30, 2022 and October 30, 2021, the Company held $951.9 million and $1,315.0 million, respectively, of cash that was excluded from the tables below. July 30, 2022 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Total Assets Cash equivalents: Available-for-sale: Government and institutional money market funds $ 573,019 $ — $ 573,019 Other assets: Deferred compensation plan investments 68,128 — 68,128 Total assets measured at fair value $ 641,147 $ — $ 641,147 Liabilities Forward foreign currency exchange contracts (1) $ — $ 23,677 $ 23,677 Total liabilities measured at fair value $ — $ 23,677 $ 23,677 (1) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements. October 30, 2021 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Total Assets Cash equivalents: Available-for-sale: Government and institutional money market funds $ 662,997 $ — $ 662,997 Other assets: Deferred compensation plan investments 71,301 — 71,301 Total assets measured at fair value $ 734,298 $ — $ 734,298 Liabilities Forward foreign currency exchange contracts (1) $ — $ 8,085 $ 8,085 Total liabilities measured at fair value $ — $ 8,085 $ 8,085 (1) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements. The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments: Cash equivalents — These investments are adjusted to fair value based on quoted market prices or are determined using a yield curve model based on current market rates. Deferred compensation plan investments — The fair value of these mutual fund, money market fund and equity investments are based on quoted market prices. Forward foreign currency exchange contracts — The estimated fair value of forward foreign currency exchange contracts, which includes derivatives that are accounted for as cash flow hedges and those that are not designated as cash flow hedges, is based on the estimated amount the Company would receive if it sold these agreements at the reporting date taking into consideration current interest rates as well as the creditworthiness of the counterparty for assets and the Company’s creditworthiness for liabilities. The fair value of these instruments is based upon valuation models using current market information such as strike price, spot rate, maturity date and volatility. Assets amd Liabilities Not Recorded at Fair Value on a Recurring Basis Santa Clara, California leased property asset group — As a result of a sublease transaction involving a leased property in Santa Clara, California during the third quarter of 2022, the Company estimated the fair value of the sublease assets using discounted cash flows from the estimated net sublease rental income discounted at a market rate and recorded an impairment charge which represented the excess carrying value of the asset group associated with the Santa Clara, California leased property over its estimated fair value. These assets are considered a Level 2 fair value measurement. See Note 5, Special Charges, Net , in these Notes to Condensed Consolidated Financial Statements for additional information. Debt — The table below presents the estimated fair value of certain financial instruments not recorded at fair value on a recurring basis. The fair values of the senior unsecured notes are obtained from broker prices and are classified as Level 1 measurements according to the fair value hierarchy. July 30, 2022 October 30, 2021 Principal Amount Outstanding Fair Value Principal Amount Outstanding Fair Value Maxim 2023 Notes, due March 2023 $ — $ — $ 500,000 $ 520,236 2024 Notes, due October 2024 500,000 489,243 500,000 500,482 2025 Notes, due April 2025 400,000 395,881 400,000 423,265 2026 Notes, due December 2026 900,000 907,976 900,000 986,243 Maxim 2027 Notes, due June 2027 500,000 488,514 500,000 542,942 2028 Notes, due October 2028 750,000 678,323 750,000 743,109 2031 Notes, due October 2031 1,000,000 891,385 1,000,000 996,702 2036 Notes, due December 2036 144,278 150,517 144,278 176,960 2041 Notes, due October 2041 750,000 631,709 750,000 758,246 2045 Notes, due December 2045 332,587 376,689 332,587 469,592 2051 Notes, due October 2051 1,000,000 816,848 1,000,000 1,029,830 Total debt $ 6,276,865 $ 5,827,085 $ 6,776,865 $ 7,147,607

Derivatives

Derivatives	9 Months Ended
	Jul. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives	Derivatives Foreign Exchange Exposure Management — The Company enters into forward foreign currency exchange contracts to offset certain operational and balance sheet exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company’s operations, assets and liabilities that are denominated in currencies other than the U.S. dollar, primarily the Euro; other significant exposures include the British Pound, Philippine Peso, Thai Baht, South Korean Won and the Japanese Yen. Derivative instruments are employed to eliminate or minimize certain foreign currency exposures that can be confidently identified and quantified. These foreign currency exchange contracts are entered into to support transactions made in the normal course of business, and accordingly, are not speculative in nature. The contracts are for periods consistent with the terms of the underlying transactions, generally one year or less. Hedges related to anticipated transactions are matched with the underlying exposures at inception and designated and documented as cash flow hedges. They are qualitatively evaluated for effectiveness on a quarterly basis. The gain or loss on the derivative is recorded as a component of AOCI in shareholders’ equity and is reclassified into earnings in the same line item on the Consolidated Statements of Income as the impact of the hedged transaction in the same period during which the hedged transaction affects earnings. The total notional amounts of forward foreign currency derivative instruments designated as hedging instruments of cash flow hedges denominated in Euros, British Pounds, Philippine Pesos, Thai Baht, South Korean Won and Japanese Yen as of July 30, 2022 and October 30, 2021 were $296.6 million and $343.6 million, respectively. The fair values of forward foreign currency derivative instruments designated as hedging instruments in the Company’s Condensed Consolidated Balance Sheets as of July 30, 2022 and October 30, 2021 were as follows: Fair Value At Balance Sheet Location July 30, 2022 October 30, 2021 Forward foreign currency exchange contracts Accrued liabilities $ 19,915 $ 7,113 As of July 30, 2022 and October 30, 2021, the total notional amounts of undesignated hedges related to forward foreign currency exchange contracts were $222.6 million and $120.0 million, respectively. The fair values of these hedging instruments in the Company’s Condensed Consolidated Balance Sheets were immaterial as of July 30, 2022 and October 30, 2021. The Company estimates $14.8 million, net of tax, of losses on forward foreign currency derivative instruments included in AOCI will be reclassified into earnings within the next twelve months. All of the Company’s derivative financial instruments are eligible for netting arrangements that allow the Company and its counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in the Company's Condensed Consolidated Balance Sheets on a net basis. As of July 30, 2022 and October 30, 2021, none of the netting arrangements involved collateral. The following table presents the gross amounts of the Company's forward foreign currency exchange contract derivative assets and liabilities and the net amounts recorded in the Company's Condensed Consolidated Balance Sheets: July 30, 2022 October 30, 2021 Gross amounts of recognized liabilities $ (24,197) $ (8,404) Gross amount of recognized assets 520 319 Net liabilities offset and presented in the Condensed Consolidated Balance Sheets $ (23,677) $ (8,085) The market risk associated with the Company’s derivative instruments results from currency exchange rate or interest rate movements that are expected to offset the market risk of the underlying transactions, assets and liabilities being hedged. The counterparties to the agreements relating to the Company’s derivative instruments consist of a number of major international financial institutions with high credit ratings. Based on the credit ratings of the Company’s counterparties as of July 30, 2022 and October 30, 2021, nonperformance is not perceived to be a material risk. Furthermore, none of the Company’s derivatives are subject to collateral or other security arrangements and none contain provisions that are dependent on the Company’s credit ratings from any credit rating agency. While the contract or notional amounts of derivative financial instruments provide one measure of the volume of these transactions, they do not represent the amount of the Company’s exposure to credit risk. The amounts potentially subject to credit risk (arising from the possible inability of counterparties to meet the terms of their contracts) are generally limited to the amounts, if any, by which the counterparties’ obligations under the contracts exceed the obligations of the Company to the counterparties. As a result of the above considerations, the Company does not consider the risk of counterparty default to be significant. For information on the unrealized holding gains (losses) on derivatives included in and reclassified out of AOCI into the Condensed Consolidated Statements of Income related to forward foreign currency exchange contracts, see Note 3, Accumulated Other Comprehensive (Loss) Income, in these Notes to Condensed Consolidated Financial Statements for further information.

Inventories

Inventories	9 Months Ended
	Jul. 30, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories at July 30, 2022 and October 30, 2021 were as follows: July 30, 2022 October 30, 2021 Raw materials $ 107,395 $ 71,639 Work in process 818,531 858,627 Finished goods 277,468 270,344 Total inventories $ 1,203,394 $ 1,200,610

Debt

Debt	9 Months Ended
	Jul. 30, 2022
Debt Disclosure [Abstract]
Debt	Debt In conjunction with the Acquisition, the Company acquired $500.0 million aggregate principal amount of Maxim’s 3.375% senior unsecured and unsubordinated notes due March 15, 2023 (the Maxim March 2023 Notes). On November 4, 2021, the Maxim March 2023 Notes were redeemed for cash at a redemption price equal to $1,038.23 for each $1,000 principal amount. On June 23, 2021, the Company entered into a Third Amended and Restated Credit Agreement (Revolving Credit Agreement) with Bank of America, N.A. as administrative agent and the other banks identified therein as lenders. The Revolving Credit Agreement provides for a five year unsecured revolving credit facility in an aggregate principal amount not to exceed $2.5 billion (subject to certain terms and conditions). In June 2022, the Company borrowed $400.0 million under this revolving credit facility and utilized the proceeds for working capital requirements. The Company repaid the $400.0 million plus interest in July 2022. As of July 30, 2022, the Company had no outstanding borrowings under this revolving credit facility but may borrow in the future and use the proceeds for repayment of existing indebtedness, stock repurchases, acquisitions, capital expenditures, working capital and other lawful corporate purposes.

Income Taxes

Income Taxes	9 Months Ended
	Jul. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company’s effective tax rates for the three- and nine-month periods ended July 30, 2022 and July 31, 2021 were below the U.S. statutory tax rate of 21.0%, due to lower statutory tax rates applicable to the Company's operations in the foreign jurisdictions in which it earns income. During the first nine months of fiscal 2022, the Company increased acquisition related tax reserves by $15.6 million consisting of $12.3 million in tax and $3.3 million in accrued interest primarily relating to tax audits. It is reasonably possible that the balance of gross unrecognized tax benefits, including accrued interest and penalties, could decrease by as much as $148.0 million within the next twelve months due to the completion of tax audits, including any administrative appeals. The Company has numerous audits ongoing throughout the world including: an IRS income tax audit for the fiscal years ended November 3, 2018 and November 2, 2019; a pre-acquisition IRS income tax audit for Maxim's fiscal years ended June 27, 2015 through June 26, 2021; various U.S. state and local audits and various international audits. The Company's U.S. federal tax returns prior to the fiscal year ended November 3, 2018 are no longer subject to examination, except for the applicable Maxim pre-Acquisition fiscal years noted above.

New Accounting Pronouncements

New Accounting Pronouncements	9 Months Ended
	Jul. 30, 2022
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Pronouncements	New Accounting Pronouncements Standards Implemented Reference Rate Reform In March 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional guidance for accounting for contracts, hedging relationships, and other transactions affected by reference rate reform, if certain criteria are met. The provisions of this standard are available for election through December 31, 2022. The Company adopted this standard in the first quarter of fiscal 2022 with no material impact on the Company's financial position and results of operations. Standards to Be Implemented Acquired Contract Assets and Contract Liabilities In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities. Under the new guidance (ASC 805-20-30-28), the acquirer should determine what

Acquisitions

Acquisitions	9 Months Ended
	Jul. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions	Acquisitions Maxim Integrated Products, Inc. On the Acquisition Date, the Company completed its acquisition of all of the voting interests of Maxim, an independent manufacturer of innovative analog and mixed-signal products and technologies. The total consideration paid to acquire Maxim, which consisted of cash, common stock of the Company and share-based compensation awards, was approximately $28.0 billion. The Company believes the combination creates an expanded suite of top-performing mixed-signal and power management technology offerings and complements the Company's legacy offerings. The results of operations of Maxim from the Acquisition Date are included in the Company’s Condensed Consolidated Statements of Income, Condensed Consolidated Statements of Comprehensive Income, Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Cash Flows and Condensed Consolidated Statement of Shareholders’ Equity for the three- and nine-month periods ended July 30, 2022. In the nine-month period ended July 30, 2022, the Company recorded acquisition accounting adjustments of $15.3 million to goodwill comprised of $19.0 million to income tax payable and $1.6 million to accrued liabilities offset by decreases of $3.5 million to deferred income taxes and $1.8 million to other non-current liabilities. The Acquisition accounting is not complete and additional information relating to conditions that existed at the Acquisition Date may become known to the Company during the remainder of the measurement period. As of the filing date of this Quarterly Report on Form 10-Q, the Company is still in the process of valuing Maxim's assets, including fixed assets, intangible assets, and liabilities, including related income tax accounting. The following unaudited pro forma consolidated financial information for the three- and nine-month periods ended July 31, 2021 combines the results of the Company for the three- and nine-month periods ended July 31, 2021 and the unaudited results of Maxim for the corresponding period. The unaudited pro forma consolidated financial information assumes that the Acquisition, which closed on August 26, 2021, was completed on November 3, 2019 (the first day of fiscal 2020). The pro forma consolidated financial information has been calculated after applying the Company’s accounting policies and includes adjustments for amortization expense of acquired intangible assets, fair value adjustments for acquired inventory, property, plant and equipment and long-term debt and compensation expense for ongoing share-based compensation arrangements that were replaced in conjunction with the Acquisition, together with the consequential tax effects. These pro forma results have been prepared for comparative purposes only and do not purport to be indicative of the operating results of the Company that would have been achieved had the Acquisition actually taken place on November 3, 2019. In addition, these results are not intended to be a projection of future results and do not reflect events that may occur after the Acquisition, including but not limited to revenue enhancements, cost savings or operating synergies that the combined Company may achieve as a result of the Acquisition. Pro Forma Three Months Ended (unaudited) Pro Forma Nine Months Ended (unaudited) July 31, 2021 July 31, 2021 Revenue $ 2,506,950 $ 7,005,648 Net income $ 485,904 $ 1,111,411 Basic net income per common share $ 0.90 $ 2.07 Diluted net income per common share $ 0.89 $ 2.04

Subsequent Events

Subsequent Events	9 Months Ended
	Jul. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsOn August 16, 2022, the Board of Directors of the Company declared a cash dividend of $0.76 per outstanding share of common stock. The dividend will be paid on September 8, 2022 to all shareholders of record at the close of business on August 30, 2022 and is expected to total approximately $390.9 million.

Basis of Presentation (Policies

Basis of Presentation (Policies)	9 Months Ended
	Jul. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Fiscal Period	The Company has a 52-53 week fiscal year that ends on the Saturday closest to the last day in October. Certain amounts reported in previous periods have been reclassified to conform to the fiscal 2022 presentation.
Fair Value	The Company defines fair value as the price that would be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments: Cash equivalents — These investments are adjusted to fair value based on quoted market prices or are determined using a yield curve model based on current market rates. Deferred compensation plan investments — The fair value of these mutual fund, money market fund and equity investments are based on quoted market prices. Forward foreign currency exchange contracts — The estimated fair value of forward foreign currency exchange contracts, which includes derivatives that are accounted for as cash flow hedges and those that are not designated as cash flow hedges, is based on the estimated amount the Company would receive if it sold these agreements at the reporting date taking into consideration current interest rates as well as the creditworthiness of the counterparty for assets and the Company’s creditworthiness for liabilities. The fair value of these instruments is based upon valuation models using current market information such as strike price, spot rate, maturity date and volatility. Assets amd Liabilities Not Recorded at Fair Value on a Recurring Basis Santa Clara, California leased property asset group — As a result of a sublease transaction involving a leased property in Santa Clara, California during the third quarter of 2022, the Company estimated the fair value of the sublease assets using discounted cash flows from the estimated net sublease rental income discounted at a market rate and recorded an impairment charge which represented the excess carrying value of the asset group associated with the Santa Clara, California leased property over its estimated fair value. These assets are considered a Level 2 fair value measurement. See Note 5, Special Charges, Net , in these Notes to Condensed Consolidated Financial Statements for additional information.
Derivatives	Foreign Exchange Exposure Management — The Company enters into forward foreign currency exchange contracts to offset certain operational and balance sheet exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company’s operations, assets and liabilities that are denominated in currencies other than the U.S. dollar, primarily the Euro; other significant exposures include the British Pound, Philippine Peso, Thai Baht, South Korean Won and the Japanese Yen. Derivative instruments are employed to eliminate or minimize certain foreign currency exposures that can be confidently identified and quantified. These foreign currency exchange contracts are entered into to support transactions made in the normal course of business, and accordingly, are not speculative in nature. The contracts are for periods consistent with the terms of the underlying transactions, generally one year or less. Hedges related to anticipated transactions are matched with the underlying exposures at inception and designated and documented as cash flow hedges. They are qualitatively evaluated for effectiveness on a quarterly basis. The gain or loss on the derivative is recorded as a component of AOCI in shareholders’ equity and is reclassified into earnings in the same line item on the Consolidated Statements of Income as the impact of the hedged transaction in the same period during which the hedged transaction affects earnings.
Standards Implemented and Standards to Be Implemented	Standards Implemented Reference Rate Reform In March 2020, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting , which provides optional guidance for accounting for contracts, hedging relationships, and other transactions affected by reference rate reform, if certain criteria are met. The provisions of this standard are available for election through December 31, 2022. The Company adopted this standard in the first quarter of fiscal 2022 with no material impact on the Company's financial position and results of operations. Standards to Be Implemented Acquired Contract Assets and Contract Liabilities In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities. Under the new guidance (ASC 805-20-30-28), the acquirer should determine what

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive (Loss) Income (Tables)	9 Months Ended
	Jul. 30, 2022
Equity [Abstract]
Components of accumulated other comprehensive loss, net of tax	The following table provides the changes in accumulated other comprehensive (loss) income (AOCI) by component and the related tax effects during the first nine months of fiscal 2022. Foreign currency translation adjustment Unrealized holding gains (losses) on derivatives Pension plans Total October 30, 2021 $ (25,795) $ (123,754) $ (37,016) $ (186,565) Other comprehensive (loss) income before reclassifications (31,500) (27,471) 4,513 (54,458) Amounts reclassified out of other comprehensive income — 28,103 1,664 29,767 Tax effects — (1,103) (275) (1,378) Other comprehensive (loss) income (31,500) (471) 5,902 (26,069) July 30, 2022 $ (57,295) $ (124,225) $ (31,114) $ (212,634)
Schedule of reclassification out of accumulated other comprehensive income	The amounts reclassified out of AOCI into the Condensed Consolidated Statements of Income and the Condensed Consolidated Statements of Shareholders' Equity with presentation location during each period were as follows: Three Months Ended Nine Months Ended Comprehensive (Loss) Income Component July 30, 2022 July 31, 2021 July 30, 2022 July 31, 2021 Location Unrealized holding (gains) losses on derivatives Currency forwards $ 2,520 $ (351) $ 6,384 $ (3,700) Cost of sales 1,320 (283) 3,903 (2,138) Research and development 2,265 28 6,623 (1,796) Selling, marketing, general and administrative Interest rate derivatives 3,731 464 11,193 1,391 Interest expense 9,836 (142) 28,103 (6,243) Total before tax (423) (28) (3,209) 505 Tax $ 9,413 $ (170) $ 24,894 $ (5,738) Net of tax Amortization of pension components included in the computation of net periodic pension cost Actuarial losses 529 747 1,664 2,245 (88) (85) (275) (257) Tax $ 441 $ 662 $ 1,389 $ 1,988 Net of tax Total amounts reclassified out of AOCI, net of tax $ 9,854 $ 492 $ 26,283 $ (3,750)

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Jul. 30, 2022
Earnings Per Share [Abstract]
Computation of basic and diluted earnings per share	The following table sets forth the computation of basic and diluted earnings per share: Three Months Ended Nine Months Ended July 30, 2022 July 31, 2021 July 30, 2022 July 31, 2021 Net Income $ 748,985 $ 503,311 $ 1,812,335 $ 1,314,735 Basic shares: Weighted-average shares outstanding 517,011 368,476 521,557 368,834 Earnings per common share basic: $ 1.45 $ 1.37 $ 3.47 $ 3.56 Diluted shares: Weighted-average shares outstanding 517,011 368,476 521,557 368,834 Assumed exercise of common stock equivalents 3,539 3,373 4,095 3,623 Weighted-average common and common equivalent shares 520,550 371,849 525,652 372,457 Earnings per common share diluted: $ 1.44 $ 1.35 $ 3.45 $ 3.53 Anti-dilutive shares related to: Outstanding stock-based awards 755 645 559 502

Special Charges, Net (Tables)

Special Charges, Net (Tables)	9 Months Ended
	Jul. 30, 2022
Restructuring and Related Activities [Abstract]
Schedule of accrued restructuring	Liabilities related to special charges, net are included in Accrued liabilities in the Condensed Consolidated Balance Sheets. The activity is detailed below: Accrued Special Charges Closure of Manufacturing Facilities Global Repositioning Actions Balance at October 30, 2021 $ 25,774 $ 21,065 Employee severance and benefit costs 75 44,411 Facility closure costs 6,513 — Severance and benefit payments (4,016) (25,776) Facility closure cost payments (6,513) — Effect of foreign currency on accrual — (54) Balance at January 29, 2022 $ 21,833 $ 39,646 Employee severance and benefit costs — 39,610 Facility closure costs 4,287 — Severance and benefit payments (14,026) (25,608) Facility closure cost payments (4,287) — Effect of foreign currency on accrual — (156) Balance at April 30, 2022 $ 7,807 $ 53,492 Employee severance and benefit costs — 49,712 Facility closure costs 888 — Severance and benefit payments (4,663) (44,638) Facility closure cost payments (1,303) — Effect of foreign currency on accrual — (35) Balance at July 30, 2022 $ 2,729 $ 58,531

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Jul. 30, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of revenue	The following table summarizes revenue by end market. The categorization of revenue by end market is determined using a variety of data points including the technical characteristics of the product, the “sold to” customer information, the “ship to” customer information and the end customer product or application into which the Company’s product will be incorporated. As data systems for capturing and tracking this data and the Company's methodology evolves and improves, the categorization of products by end market can vary over time. When this occurs, the Company reclassifies revenue by end market for prior periods. Such reclassifications typically do not materially change the sizing of, or the underlying trends of revenue within, each end market. Three Months Ended July 30, 2022 July 31, 2021 Revenue % of Revenue* Y/Y% Revenue % of Revenue* Industrial $ 1,555,070 50 % 55 % $ 1,006,383 57 % Automotive 659,090 21 % 127 % 290,182 16 % Communications 490,732 16 % 69 % 290,391 17 % Consumer 404,988 13 % 136 % 171,897 10 % Total revenue $ 3,109,880 100 % 77 % $ 1,758,853 100 % Nine Months Ended July 30, 2022 July 31, 2021 Revenue % of Revenue* Y/Y% Revenue % of Revenue* Industrial $ 4,402,912 50 % 55 % $ 2,841,665 57 % Automotive 1,844,017 21 % 132 % 794,739 16 % Communications 1,376,182 16 % 62 % 850,153 17 % Consumer 1,143,126 13 % 132 % 492,161 10 % Total revenue $ 8,766,237 100 % 76 % $ 4,978,718 100 % * The sum of the individual percentages may not equal the total due to rounding. Revenue by Sales Channel The following table summarizes revenue by channel. The Company sells its products globally through a direct sales force, third party distributors, independent sales representatives and via its website. Distributors are customers that buy products with the intention of reselling them. Direct customers are non-distributor customers and consist primarily of original equipment manufacturers (OEMs). Other customers include the U.S. government, government prime contractors and certain commercial customers for which revenue is recorded over time. Three Months Ended July 30, 2022 July 31, 2021 Channel Revenue % of Revenue* Revenue % of Revenue* Distributors $ 1,922,982 62 % $ 1,123,301 64 % Direct customers 1,146,538 37 % 588,001 33 % Other 40,360 1 % 47,551 3 % Total revenue $ 3,109,880 100 % $ 1,758,853 100 % Nine Months Ended July 30, 2022 July 31, 2021 Channel Revenue % of Revenue* Revenue % of Revenue* Distributors $ 5,426,024 62 % $ 3,162,615 64 % Direct customers 3,241,429 37 % 1,724,012 35 % Other 98,784 1 % 92,091 2 % Total revenue $ 8,766,237 100 % $ 4,978,718 100 % * The sum of the individual percentages may not equal the total due to rounding.

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Jul. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of fair value of financial assets and liabilities	The tables below, set forth by level, presents the Company’s financial assets and liabilities, excluding accrued interest components that were accounted for at fair value on a recurring basis as of July 30, 2022 and October 30, 2021. The tables exclude cash on hand and assets and liabilities that are measured at historical cost or any basis other than fair value. As of July 30, 2022 and October 30, 2021, the Company held $951.9 million and $1,315.0 million, respectively, of cash that was excluded from the tables below. July 30, 2022 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Total Assets Cash equivalents: Available-for-sale: Government and institutional money market funds $ 573,019 $ — $ 573,019 Other assets: Deferred compensation plan investments 68,128 — 68,128 Total assets measured at fair value $ 641,147 $ — $ 641,147 Liabilities Forward foreign currency exchange contracts (1) $ — $ 23,677 $ 23,677 Total liabilities measured at fair value $ — $ 23,677 $ 23,677 (1) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements. October 30, 2021 Fair Value measurement at Reporting Date using: Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Total Assets Cash equivalents: Available-for-sale: Government and institutional money market funds $ 662,997 $ — $ 662,997 Other assets: Deferred compensation plan investments 71,301 — 71,301 Total assets measured at fair value $ 734,298 $ — $ 734,298 Liabilities Forward foreign currency exchange contracts (1) $ — $ 8,085 $ 8,085 Total liabilities measured at fair value $ — $ 8,085 $ 8,085 (1) The Company has master netting arrangements by counterparty with respect to derivative contracts. See Note 9, Derivatives, in these Notes to Condensed Consolidated Financial Statements for more information related to the Company's master netting arrangements.
Schedule of debt	The table below presents the estimated fair value of certain financial instruments not recorded at fair value on a recurring basis. The fair values of the senior unsecured notes are obtained from broker prices and are classified as Level 1 measurements according to the fair value hierarchy. July 30, 2022 October 30, 2021 Principal Amount Outstanding Fair Value Principal Amount Outstanding Fair Value Maxim 2023 Notes, due March 2023 $ — $ — $ 500,000 $ 520,236 2024 Notes, due October 2024 500,000 489,243 500,000 500,482 2025 Notes, due April 2025 400,000 395,881 400,000 423,265 2026 Notes, due December 2026 900,000 907,976 900,000 986,243 Maxim 2027 Notes, due June 2027 500,000 488,514 500,000 542,942 2028 Notes, due October 2028 750,000 678,323 750,000 743,109 2031 Notes, due October 2031 1,000,000 891,385 1,000,000 996,702 2036 Notes, due December 2036 144,278 150,517 144,278 176,960 2041 Notes, due October 2041 750,000 631,709 750,000 758,246 2045 Notes, due December 2045 332,587 376,689 332,587 469,592 2051 Notes, due October 2051 1,000,000 816,848 1,000,000 1,029,830 Total debt $ 6,276,865 $ 5,827,085 $ 6,776,865 $ 7,147,607

Derivatives (Tables)

Derivatives (Tables)	9 Months Ended
	Jul. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of fair value of hedging instruments	The fair values of forward foreign currency derivative instruments designated as hedging instruments in the Company’s Condensed Consolidated Balance Sheets as of July 30, 2022 and October 30, 2021 were as follows: Fair Value At Balance Sheet Location July 30, 2022 October 30, 2021 Forward foreign currency exchange contracts Accrued liabilities $ 19,915 $ 7,113
Schedule of net amount of derivative assets and liabilities	The following table presents the gross amounts of the Company's forward foreign currency exchange contract derivative assets and liabilities and the net amounts recorded in the Company's Condensed Consolidated Balance Sheets: July 30, 2022 October 30, 2021 Gross amounts of recognized liabilities $ (24,197) $ (8,404) Gross amount of recognized assets 520 319 Net liabilities offset and presented in the Condensed Consolidated Balance Sheets $ (23,677) $ (8,085)

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Jul. 30, 2022
Inventory Disclosure [Abstract]
Schedule of inventories	Inventories at July 30, 2022 and October 30, 2021 were as follows: July 30, 2022 October 30, 2021 Raw materials $ 107,395 $ 71,639 Work in process 818,531 858,627 Finished goods 277,468 270,344 Total inventories $ 1,203,394 $ 1,200,610

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Jul. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Unaudited pro forma consolidated financial information	The following unaudited pro forma consolidated financial information for the three- and nine-month periods ended July 31, 2021 combines the results of the Company for the three- and nine-month periods ended July 31, 2021 and the unaudited results of Maxim for the corresponding period. The unaudited pro forma consolidated financial information assumes that the Acquisition, which closed on August 26, 2021, was completed on November 3, 2019 (the first day of fiscal 2020). The pro forma consolidated financial information has been calculated after applying the Company’s accounting policies and includes adjustments for amortization expense of acquired intangible assets, fair value adjustments for acquired inventory, property, plant and equipment and long-term debt and compensation expense for ongoing share-based compensation arrangements that were replaced in conjunction with the Acquisition, together with the consequential tax effects. These pro forma results have been prepared for comparative purposes only and do not purport to be indicative of the operating results of the Company that would have been achieved had the Acquisition actually taken place on November 3, 2019. In addition, these results are not intended to be a projection of future results and do not reflect events that may occur after the Acquisition, including but not limited to revenue enhancements, cost savings or operating synergies that the combined Company may achieve as a result of the Acquisition. Pro Forma Three Months Ended (unaudited) Pro Forma Nine Months Ended (unaudited) July 31, 2021 July 31, 2021 Revenue $ 2,506,950 $ 7,005,648 Net income $ 485,904 $ 1,111,411 Basic net income per common share $ 0.90 $ 2.07 Diluted net income per common share $ 0.89 $ 2.04

Shareholders' Equity (Details)

Shareholders' Equity (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended	12 Months Ended	21 Months Ended
	Jan. 29, 2022	Oct. 30, 2021	Jul. 30, 2022
Stockholders' Equity Note [Abstract]
Stock repurchase program, authorized amount		$ 2,500	$ 10,900
Stock repurchased during period (in shares)	2.1	12.3	14.4
Initial purchase, percentage of common stock underlying agreement		80%
Remaining purchase, percentage of common stock underlying agreement		20%
Stock repurchase program, remaining authorized repurchase amount		$ 500	$ 5,700
Stock repurchase program, average price per share (in dollars per shares)			$ 173.77
Number of shares authorized to be repurchased (in shares)			184.3

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive (Loss) Income - Changes By Component and Tax Effect (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			$ 37,992,542
Other comprehensive (loss) income before reclassifications			(54,458)
Amounts reclassified out of other comprehensive income			29,767
Tax effects			(1,378)
Other comprehensive (loss) income	$ (5,019)	$ (42,028)	(26,069)	$ 24,518
Ending balance	36,638,591		36,638,591
AOCI
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(207,615)	(182,915)	(186,565)	(249,461)
Other comprehensive (loss) income	(5,019)	(42,028)	(26,069)	24,518
Ending balance	(212,634)	$ (224,943)	(212,634)	$ (224,943)
Foreign currency translation adjustment
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(25,795)
Other comprehensive (loss) income before reclassifications			(31,500)
Amounts reclassified out of other comprehensive income			0
Tax effects			0
Other comprehensive (loss) income			(31,500)
Ending balance	(57,295)		(57,295)
Unrealized holding gains (losses) on derivatives
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(123,754)
Other comprehensive (loss) income before reclassifications			(27,471)
Amounts reclassified out of other comprehensive income			28,103
Tax effects			(1,103)
Other comprehensive (loss) income			(471)
Ending balance	(124,225)		(124,225)
Pension plans
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance			(37,016)
Other comprehensive (loss) income before reclassifications			4,513
Amounts reclassified out of other comprehensive income			1,664
Tax effects			(275)
Other comprehensive (loss) income			5,902
Ending balance	$ (31,114)		$ (31,114)

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive (Loss) Income - Amounts Reclassified Out of Accumulated Other Comprehensive (Loss) Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	$ 1,066,738	$ 537,669	$ 3,376,578	$ 1,575,526
Research and development	431,829	306,617	1,279,510	897,005
Selling, marketing, general and administrative	326,942	206,076	929,615	597,963
Interest expense	51,189	44,659	152,701	130,204
Income before income taxes	(847,937)	(572,278)	(2,050,737)	(1,484,881)
Tax	98,952	68,967	238,402	170,146
Net income	(748,985)	(503,311)	(1,812,335)	(1,314,735)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net income	9,854	492	26,283	(3,750)
Reclassification out of Accumulated Other Comprehensive Income | Unrealized holding (gains) losses on derivatives
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income before income taxes	9,836	(142)	28,103	(6,243)
Tax	(423)	(28)	(3,209)	505
Net income	9,413	(170)	24,894	(5,738)
Reclassification out of Accumulated Other Comprehensive Income | Pension plans
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Income before income taxes	529	747	1,664	2,245
Tax	(88)	(85)	(275)	(257)
Net income	441	662	1,389	1,988
Reclassification out of Accumulated Other Comprehensive Income | Currency forwards | Unrealized holding (gains) losses on derivatives
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	2,520	(351)	6,384	(3,700)
Research and development	1,320	(283)	3,903	(2,138)
Selling, marketing, general and administrative	2,265	28	6,623	(1,796)
Reclassification out of Accumulated Other Comprehensive Income | Interest rate derivatives | Unrealized holding (gains) losses on derivatives
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Interest expense	$ 3,731	$ 464	$ 11,193	$ 1,391

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021
Earnings per share
Net Income	$ 748,985	$ 503,311	$ 1,812,335	$ 1,314,735
Basic shares:
Weighted-average shares outstanding (in shares)	517,011	368,476	521,557	368,834
Earnings per common share, basic (in dollars per share)	$ 1.45	$ 1.37	$ 3.47	$ 3.56
Diluted shares:
Assumed exercise of common stock equivalents (in shares)	3,539	3,373	4,095	3,623
Weighted-average common and common equivalent shares (in shares)	520,550	371,849	525,652	372,457
Earnings per common share, diluted (in dollars per share)	$ 1.44	$ 1.35	$ 3.45	$ 3.53
Anti-dilutive shares related to:
Outstanding share-based awards (in shares)	755	645	559	502

Special Charges, Net - Balance

Special Charges, Net - Balance Sheet Impact (Details) - USD ($) $ in Thousands	3 Months Ended
	Jul. 30, 2022	Apr. 30, 2022	Jan. 29, 2022
Closure of Manufacturing Facilities
Restructuring Reserve [Roll Forward]
Accrued restructuring, beginning balance	$ 7,807	$ 21,833	$ 25,774
Employee severance and benefit costs	0	0	75
Facility closure costs	888	4,287	6,513
Severance and benefit payments	(4,663)	(14,026)	(4,016)
Facility closure cost payments	(1,303)	(4,287)	(6,513)
Effect of foreign currency on accrual	0	0	0
Accrued restructuring, ending balance	2,729	7,807	21,833
Global Repositioning Actions
Restructuring Reserve [Roll Forward]
Accrued restructuring, beginning balance	53,492	39,646	21,065
Employee severance and benefit costs	49,712	39,610	44,411
Facility closure costs	0	0	0
Severance and benefit payments	(44,638)	(25,608)	(25,776)
Facility closure cost payments	0	0	0
Effect of foreign currency on accrual	(35)	(156)	(54)
Accrued restructuring, ending balance	$ 58,531	$ 53,492	$ 39,646

Special Charges, Net - Textual

Special Charges, Net - Textual (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021	Oct. 30, 2021
Restructuring Cost and Reserve [Line Items]
Gain on sale of property, plant, and equipment			$ 4,352	$ 13,557
Impairment charges			91,953	0
Special charges, net	$ 138,201	$ (8,938)	244,603	$ (8,189)
Closure of Manufacturing Facilities
Restructuring Cost and Reserve [Line Items]
Special charges, cumulative	63,400		63,400
Closure of Manufacturing Facilities | Milpitas, California | Hillview Wafer Fab Facility | Discontinued Operations, Disposed of by Sale
Restructuring Cost and Reserve [Line Items]
Consideration from sale of facility	31,800		31,800
Gain on sale of property, plant, and equipment	4,400
Closure of Manufacturing Facilities | Singapore | Facility and Certain Equipment | Discontinued Operations, Disposed of by Sale
Restructuring Cost and Reserve [Line Items]
Consideration from sale of facility					$ 35,700
Gain on sale of property, plant, and equipment					$ 13,600
Global Repositioning Actions
Restructuring Cost and Reserve [Line Items]
Special charges, cumulative	458,100		458,100
Impairment charges	91,900
Impairment charge for right of use assets	60,600
Special charges, net			145,200
Employee severance, benefit costs and employee equity acceleration charge			153,500
Gain on sale of business			$ 8,300
Global Repositioning Actions | Leasehold Improvements
Restructuring Cost and Reserve [Line Items]
Impairment charge for held for use assets	28,100
Global Repositioning Actions | Office equipment
Restructuring Cost and Reserve [Line Items]
Impairment charge for held for use assets	$ 3,200

Revenue - Revenue Trends by Seg

Revenue - Revenue Trends by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 3,109,880	$ 1,758,853	$ 8,766,237	$ 4,978,718
Percent of Revenue (as percent)	100%	100%	100%	100%
Year over Year Change (as percent)	77%		76%
Industrial
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 1,555,070	$ 1,006,383	$ 4,402,912	$ 2,841,665
Percent of Revenue (as percent)	50%	57%	50%	57%
Year over Year Change (as percent)	55%		55%
Automotive
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 659,090	$ 290,182	$ 1,844,017	$ 794,739
Percent of Revenue (as percent)	21%	16%	21%	16%
Year over Year Change (as percent)	127%		132%
Communications
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 490,732	$ 290,391	$ 1,376,182	$ 850,153
Percent of Revenue (as percent)	16%	17%	16%	17%
Year over Year Change (as percent)	69%		62%
Consumer
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 404,988	$ 171,897	$ 1,143,126	$ 492,161
Percent of Revenue (as percent)	13%	10%	13%	10%
Year over Year Change (as percent)	136%		132%

Revenue - Revenue by Sales Chan

Revenue - Revenue by Sales Channel (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 3,109,880	$ 1,758,853	$ 8,766,237	$ 4,978,718
Percent of Revenue (as percent)	100%	100%	100%	100%
Distributors
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 1,922,982	$ 1,123,301	$ 5,426,024	$ 3,162,615
Percent of Revenue (as percent)	62%	64%	62%	64%
Direct customers
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 1,146,538	$ 588,001	$ 3,241,429	$ 1,724,012
Percent of Revenue (as percent)	37%	33%	37%	35%
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 40,360	$ 47,551	$ 98,784	$ 92,091
Percent of Revenue (as percent)	1%	3%	1%	2%

Fair Value - Textual (Details)

Fair Value - Textual (Details) - USD ($) $ in Millions	Jul. 30, 2022	Oct. 30, 2021
Fair Value Disclosures [Abstract]
Cash	$ 951.9	$ 1,315

Fair Value - Assets and Liabili

Fair Value - Assets and Liabilities (Details) - Recurring - USD ($) $ in Thousands	Jul. 30, 2022	Oct. 30, 2021
Other assets:
Deferred compensation plan investments	$ 68,128	$ 71,301
Total assets measured at fair value	641,147	734,298
Liabilities
Forward foreign currency exchange contracts	23,677	8,085
Total liabilities measured at fair value	23,677	8,085
Government and institutional money market funds
Available-for-sale:
Cash equivalents available for sale	573,019	662,997
Level 1
Other assets:
Deferred compensation plan investments	68,128	71,301
Total assets measured at fair value	641,147	734,298
Liabilities
Forward foreign currency exchange contracts	0	0
Total liabilities measured at fair value	0	0
Level 1 | Government and institutional money market funds
Available-for-sale:
Cash equivalents available for sale	573,019	662,997
Level 2
Other assets:
Deferred compensation plan investments	0	0
Total assets measured at fair value	0	0
Liabilities
Forward foreign currency exchange contracts	23,677	8,085
Total liabilities measured at fair value	23,677	8,085
Level 2 | Government and institutional money market funds
Available-for-sale:
Cash equivalents available for sale	$ 0	$ 0

Fair Value - Debt (Details)

Fair Value - Debt (Details) - USD ($) $ in Thousands	Jul. 30, 2022	Oct. 30, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	$ 6,276,865	$ 6,776,865
Fair Value	5,827,085,000	7,147,607
Maxim 2023 Notes, due March 2023 | Senior notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	0	500,000
Fair Value	0	520,236
2024 Notes, due October 2024 | Senior notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	500,000	500,000
Fair Value	489,243,000	500,482
2025 Notes, due April 2025 | Senior notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	400,000	400,000
Fair Value	395,881,000	423,265
2026 Notes, due December 2026 | Senior notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	900,000	900,000
Fair Value	907,976,000	986,243
Maxim 2027 Notes, due June 2027 | Senior notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	500,000	500,000
Fair Value	488,514,000	542,942
2028 Notes, due October 2028 | Senior notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	750,000	750,000
Fair Value	678,323,000	743,109
2031 Notes, due October 2031 | Senior notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	1,000,000	1,000,000
Fair Value	891,385,000	996,702
2036 Notes, due December 2036 | Senior notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	144,278	144,278
Fair Value	150,517,000	176,960
2041 Notes, due October 2041 | Senior notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	750,000	750,000
Fair Value	631,709,000	758,246
2045 Notes, due December 2045 | Senior notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	332,587	332,587
Fair Value	376,689,000	469,592
2051 Notes, due October 2051 | Senior notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal Amount Outstanding	1,000,000	1,000,000
Fair Value	$ 816,848,000	$ 1,029,830

Derivatives - Textual (Details)

Derivatives - Textual (Details) - USD ($) $ in Millions	9 Months Ended
	Jul. 30, 2022	Oct. 30, 2021
Derivative [Line Items]
Contracts period	1 year
Forward Contracts
Derivative [Line Items]
Notional amount of cash flow hedges	$ 296.6	$ 343.6
Notional amount of derivative	222.6	$ 120
Cash flow hedge loss to be reclassified within twelve months	$ 14.8

Derivatives - Forward Foreign C

Derivatives - Forward Foreign Currency (Details) - USD ($) $ in Thousands	Jul. 30, 2022	Oct. 30, 2021
Forward foreign currency exchange contracts | Accrued liabilities
Derivatives, Fair Value [Line Items]
Foreign currency contracts, liability	$ 19,915	$ 7,113

Derivative - Net Amounts (Detai

Derivative - Net Amounts (Details) - USD ($) $ in Thousands	Jul. 30, 2022	Oct. 30, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Gross amounts of recognized liabilities	$ (24,197)	$ (8,404)
Gross amount of recognized assets	520	319
Net liabilities offset and presented in the Condensed Consolidated Balance Sheets	$ (23,677)	$ (8,085)

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Jul. 30, 2022	Oct. 30, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 107,395	$ 71,639
Work in process	818,531	858,627
Finished goods	277,468	270,344
Total inventories	$ 1,203,394	$ 1,200,610

Debt (Details)

Debt (Details) - USD ($)			1 Months Ended		9 Months Ended
	Nov. 04, 2021	Jun. 23, 2021	Jul. 30, 2022	Jun. 30, 2022	Jul. 30, 2022	Jul. 31, 2021	Oct. 30, 2021	Aug. 26, 2021
Debt Instrument [Line Items]
Proceeds from revolver					$ 400,000,000	$ 0
Payments on revolver					400,000,000	$ 0
Long-term debt			$ 6,276,865,000		6,276,865,000		$ 6,776,865,000
Revolving credit facility
Debt Instrument [Line Items]
Debt instrument, term		5 years
Amount available under credit facility		$ 2,500,000,000
Proceeds from revolver				$ 400,000,000
Payments on revolver			400,000,000
Long-term debt			0		0
Senior notes | Maxim 2023 Notes, due March 2023
Debt Instrument [Line Items]
Redemption price percentage	103.823%
Long-term debt			$ 0		$ 0		$ 500,000,000
Maxim | Senior notes | Maxim 2023 Notes, due March 2023
Debt Instrument [Line Items]
Principal								$ 500,000,000
Interest rate								3.375%

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jul. 30, 2022	Jul. 31, 2021	Jul. 30, 2022	Jul. 31, 2021
Income Tax Contingency [Line Items]
Federal statutory rate (as percent)	21%	21%	21%	21%
Maxim
Income Tax Contingency [Line Items]
Unrecognized tax benefits, income tax penalties accrued and tax	$ 15.6		$ 15.6
Unrecognized tax benefits, tax			12.3
Unrecognized tax benefits, accrued interest	3.3		3.3
Maxim | Settlement with Taxing Authority
Income Tax Contingency [Line Items]
Decrease in unrecognized tax benefits is reasonably possible	$ 148		$ 148

Acquisitions - Textual (Details

Acquisitions - Textual (Details) - Maxim - USD ($) $ in Millions		9 Months Ended
	Aug. 26, 2021	Jul. 30, 2022
Business Acquisition [Line Items]
Consideration transferred	$ 28,000
Goodwill adjustment		$ 15.3
Adjustment, income taxes payable		19
Adjustment, accrued liabilities		1.6
Adjustment, deferred income taxes		3.5
Adjustment, other non-current liabilities		$ 1.8

Acquisitions - Pro Forma Financ

Acquisitions - Pro Forma Financial Information (Details) - Maxim - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	9 Months Ended
	Jul. 31, 2021	Jul. 31, 2021
Business Acquisition [Line Items]
Revenue	$ 2,506,950	$ 7,005,648
Net income	$ 485,904	$ 1,111,411
Basic net income per common share (in dollars per share)	$ 0.90	$ 2.07
Diluted net income per common share (in dollars per share)	$ 0.89	$ 2.04

Subsequent Events (Details)

Subsequent Events (Details) - Common Stock - Subsequent event $ / shares in Units, $ in Millions	Aug. 16, 2022 USD ($) $ / shares
Subsequent Event [Line Items]
Common stock cash dividends per share, declared (in dollars per share) | $ / shares	$ 0.76
Dividends | $	$ 390.9